| GlaxoSmithKline AG - Relvar Ellipta 184/22 mcg, Einzeldosiertes Pulver zur Inhalation |
| 62969 | | 02 | | Relvar Ellipta 184/22 mcg | | Einzeldosiertes Pulver zur Inhalation | | R03AK10 | | Vilanterol and Fluticasone Furoate | | 09.01.2014 | | |
|
| Composition |
| fluticasoni furoas 184 µg, vilanterolum 22 µg ut vilanteroli trifenatas, excipiens ad pulverem pro dosi. |
| Packungsbestandteile |
| Einzeldosiertes Pulver zur Inhalation | | | | | | | | Active Agent | Dose |
|---|
| Fluticasoni Furoas | 184 µg | | Vilanterolum | 22 µg |
| | BAG: Active Agent | Dose |
|---|
| Fluticasoni Furoas | 184 mcg | | Vilanterolum | 22 mcg |
|
|
|
